Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534520 Antiviral compounds
03/18/2003US6534519 Phenanthridine-N-oxides with PDE-IV inhibiting activity
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534517 A polycyclic or heteropolycyclic compound containing amide or carboxy groups useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the peroxisome proliferator-activated receptor(PPAR)
03/18/2003US6534515 20,21-dinor-eburnamenines
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534510 Anticoagulants
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534508 Treatment of Mycobacteria infection by administering (S)-lomefloxacin or a pharmaceutically acceptable salt thereof free of its (R)-stereoisomer
03/18/2003US6534507 Methods for treating psychological disorders using bioactive metabolites of gepirone
03/18/2003US6534505 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534503 Melanocortin receptor-3 ligands to treat sexual dysfunction
03/18/2003US6534501 Allosteric inhibitors of pyruvate kinase
03/18/2003US6534500 Use of cyamemazine in the treatment of abrupt benzodiazephine withdrawal
03/18/2003US6534499 For therapy of autoimmune disease
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534497 Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534490 Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds
03/18/2003US6534489 Organophosphorus compounds and the use thereof
03/18/2003US6534488 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in
03/18/2003US6534487 Methods for suppressing appetite and enhancing exercise and recovery
03/18/2003US6534486 With broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534481 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin
03/18/2003US6534283 Method for treatment and prevention of physiological shock
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534110 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
03/18/2003US6534096 Carboplatin analogs for cancer treatment
03/18/2003US6534093 Immediate release eplerenone compositions
03/18/2003US6534092 Method for preparing microparticles having a selected polymer molecular weight
03/18/2003US6534088 Fibrate-statin combinations with reduced fed-fasted effects
03/18/2003US6534087 Process for preparing a pharmaceutical composition
03/18/2003US6534086 Composition and method for treatment of inflammation and pain in mammals
03/18/2003US6534085 Phytochemicals for promoting weight loss
03/18/2003US6534082 Method of treating disorders of the eye
03/18/2003US6534081 Administration of microparticles in a form suitable for injection and containing active agents suitable for treating or diagonising a disease or painful condition in joints in a patient in need, safe and effective procedure; sustained
03/18/2003US6534080 Method for administering camptothecins via injection of pharmaceutical composition comprising coated particles of a camptothecin
03/18/2003US6534073 Skin care cosmetic compositions containing carboxymethylates of branched alcohols and/or ethoxylates thereof
03/18/2003US6534070 Composition with azelaic acid
03/18/2003US6534069 Disinfectant, antimicrobial hand lotion comprising thickener, emulsifier, lower alcohol and water
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534049 Synthetic soil-extract materials and medicaments for human immunodeficiency viruses based thereon
03/18/2003US6534048 Aqueous gel in unit dose form for topical delivery
03/18/2003US6534018 Precisely controlled in line metering system for mixing suspensions, emulsions, ointments and creams
03/18/2003US6533767 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
03/18/2003US6532955 Metered dose inhaler for albuterol
03/18/2003CA2678495A1 Disinfectant composition including quaternary ammonium salt and alkanolamine
03/18/2003CA2422709A1 Substituted cinnamic acid guanidides, method for the production thereof,their use as a medicament, and to a medicament containing these compounds
03/18/2003CA2422500A1 Triazolo-epothilones
03/18/2003CA2403495A1 Physically stable sprayable gel composition
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2360311C Improved dialysis solutions and methods
03/18/2003CA2299231C Compressed nitroglycerin tablet and its method of manufacture
03/18/2003CA2298093C An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/18/2003CA2268028C 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
03/18/2003CA2259330C Improvement of male fertility with antioxidants and/or polyunsaturated fatty acids
03/18/2003CA2244501C Arylsulfonylamino hydroxamic acid derivatives
03/18/2003CA2239420C Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/18/2003CA2231223C Novel composition containing an acid-labile omeprazole and process for its preparation
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/18/2003CA2216417C Controlled release of miotic and mydriatic drugs in the anterior chamber
03/18/2003CA2194153C Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2071983C Beta-phenylisoserine derivative, preparation and use thereof
03/14/2003WO2002021932A2 Animal feed, feed additive and therapeutic agent against intestinal inflammation
03/14/2003CA2422250A1 Animal feed, animal feed additive and medicament for intestinal inflammation
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020926A1 Stable episomal vectors
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020771A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use
03/13/2003WO2003020768A1 A method for the treatment or prevention of bone erosion
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds
03/13/2003WO2003020744A1 Methylene-4-azasteroids
03/13/2003WO2003020739A2 Novel lna compositions and uses thereof
03/13/2003WO2003020736A1 Crystaline clindamycin free base
03/13/2003WO2003020732A2 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors.
03/13/2003WO2003020730A1 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
03/13/2003WO2003020729A1 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANT IVIRAL AGENTS
03/13/2003WO2003020728A1 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
03/13/2003WO2003020727A1 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
03/13/2003WO2003020726A1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020723A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
03/13/2003WO2003020722A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
1 ... 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 5553 ... 7860